Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 Sep 24 | ALIM Alimera Sciences | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.42 | 36,713 | 125.56 k | 0 |
16 May 24 | RGEN Repligen | Common Stock | Grant | Acquire A | No | No | 0 | 701 | 0.00 | 793 |
16 May 24 | RGEN Repligen | Stock Option Common Stock | Grant | Acquire A | No | No | 171.03 | 1,376 | 235.34 k | 1,376 |
18 Mar 24 | RGEN Repligen | Common Stock | Grant | Acquire A | No | No | 0 | 92 | 0.00 | 92 |
18 Mar 24 | RGEN Repligen | Stock Option Common Stock | Grant | Acquire A | No | No | 194.25 | 2,236 | 434.34 k | 2,236 |
18 Mar 24 | RGEN Repligen | Stock Option Common Stock | Grant | Acquire A | No | No | 194.25 | 195 | 37.88 k | 195 |
7 Nov 23 | ALIM Alimera Sciences | Stock Option Common Stock | Grant | Acquire A | No | No | 3.42 | 36,713 | 125.56 k | 36,713 |